カテゴリー： Market Monitor Global, 世界, 医療/バイオ

免疫グロブリンG抗体治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Immunoglobulin G Antibody Therapeutics Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8804 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：68 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥487,500	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥633,750	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥731,250	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Immunoglobulin G Antibody Therapeutics Market 調査レポートは次の情報を含め、グローバルにおけるの免疫グロブリンG抗体治療薬市場規模と予測を収録しています。・世界の免疫グロブリンG抗体治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の免疫グロブリンG抗体治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の免疫グロブリンG抗体治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「IgG1」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

免疫グロブリンG抗体治療薬のグローバル主要企業は、Roche、 Abbvie、 J & J、 Bristol-Myers Squibb、 Novartis、 Merck、 Alexion Pharmaceuticals、 Takeda、 Amgen、 Biogen、 UCB、 Eli Lilly and Company、 AstraZenecaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、免疫グロブリンG抗体治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の免疫グロブリンG抗体治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の免疫グロブリンG抗体治療薬市場：タイプ別市場シェア、2022年
・IgG1、IgG4、その他

世界の免疫グロブリンG抗体治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の免疫グロブリンG抗体治療薬市場：用途別市場シェア、2022年
・自己免疫、腫瘍、その他

世界の免疫グロブリンG抗体治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の免疫グロブリンG抗体治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における免疫グロブリンG抗体治療薬のグローバル売上、2018年-2023年
・主要企業における免疫グロブリンG抗体治療薬のグローバル売上シェア、2022年
・主要企業における免疫グロブリンG抗体治療薬のグローバル販売量、2018年-2023年
・主要企業における免疫グロブリンG抗体治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Roche、 Abbvie、 J & J、 Bristol-Myers Squibb、 Novartis、 Merck、 Alexion Pharmaceuticals、 Takeda、 Amgen、 Biogen、 UCB、 Eli Lilly and Company、 AstraZeneca

*************************************************************

・調査・分析レポートの概要
免疫グロブリンG抗体治療薬市場の定義
市場セグメント
世界の免疫グロブリンG抗体治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の免疫グロブリンG抗体治療薬市場規模
世界の免疫グロブリンG抗体治療薬市場規模：2022年 VS 2029年
世界の免疫グロブリンG抗体治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの免疫グロブリンG抗体治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の免疫グロブリンG抗体治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：IgG1、IgG4、その他
免疫グロブリンG抗体治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：自己免疫、腫瘍、その他
免疫グロブリンG抗体治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別免疫グロブリンG抗体治療薬市場規模 2022年と2029年
地域別免疫グロブリンG抗体治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Roche、 Abbvie、 J & J、 Bristol-Myers Squibb、 Novartis、 Merck、 Alexion Pharmaceuticals、 Takeda、 Amgen、 Biogen、 UCB、 Eli Lilly and Company、 AstraZeneca
...

Antibody, also called immunoglobulin, a protective protein produced by the immune system in response to the presence of a foreign substance, called an antigen. Antibodies recognize and latch onto antigens in order to remove them from the body. A wide range of substances are regarded by the body as antigens, including disease-causing organisms and toxic materials such as insect venom.

Treatment that uses antibodies to help the body fight cancer, infection, or other diseases. Antibodies are proteins made by the immune system that bind to specific markers on cells or tissues. IgG1 antibodies are a type of antibody made in the laboratory that can be used in diagnosis or treatment. In cancer treatment, IgG1 antibodies may kill cancer cells directly, they may block development of tumor blood vessels, or they may help the immune system kill cancer cells.
This report aims to provide a comprehensive presentation of the global market for Immunoglobulin G Antibody Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunoglobulin G Antibody Therapeutics. This report contains market size and forecasts of Immunoglobulin G Antibody Therapeutics in global, including the following market information:
Global Immunoglobulin G Antibody Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Immunoglobulin G Antibody Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The industry’s leading producers are Roche, Abbvie and J & J, with revenues of 15.61%, 12.10% and 10.05% in 2019.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Immunoglobulin G Antibody Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immunoglobulin G Antibody Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Immunoglobulin G Antibody Therapeutics Market Segment Percentages, by Type, 2022 (%)
IgG1
IgG4
Others
Global Immunoglobulin G Antibody Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Immunoglobulin G Antibody Therapeutics Market Segment Percentages, by Application, 2022 (%)
Autoimmune
Tumor
Others
Global Immunoglobulin G Antibody Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Immunoglobulin G Antibody Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immunoglobulin G Antibody Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Immunoglobulin G Antibody Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Abbvie
J & J
Bristol-Myers Squibb
Novartis
Merck
Alexion Pharmaceuticals
Takeda
Amgen
Biogen
UCB
Eli Lilly and Company
AstraZeneca
Outline of Major Chapters:
Chapter 1: Introduces the definition of Immunoglobulin G Antibody Therapeutics, market overview.
Chapter 2: Global Immunoglobulin G Antibody Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Immunoglobulin G Antibody Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Immunoglobulin G Antibody Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Immunoglobulin G Antibody Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immunoglobulin G Antibody Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immunoglobulin G Antibody Therapeutics Overall Market Size
2.1 Global Immunoglobulin G Antibody Therapeutics Market Size: 2022 VS 2029
2.2 Global Immunoglobulin G Antibody Therapeutics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Immunoglobulin G Antibody Therapeutics Players in Global Market
3.2 Top Global Immunoglobulin G Antibody Therapeutics Companies Ranked by Revenue
3.3 Global Immunoglobulin G Antibody Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Immunoglobulin G Antibody Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Immunoglobulin G Antibody Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Immunoglobulin G Antibody Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Immunoglobulin G Antibody Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Immunoglobulin G Antibody Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Immunoglobulin G Antibody Therapeutics Market Size Markets, 2022 & 2029
4.1.2 IgG1
4.1.3 IgG4
4.1.4 Others
4.2 By Type – Global Immunoglobulin G Antibody Therapeutics Revenue & Forecasts
4.2.1 By Type – Global Immunoglobulin G Antibody Therapeutics Revenue, 2018-2023
4.2.2 By Type – Global Immunoglobulin G Antibody Therapeutics Revenue, 2024-2029
4.2.3 By Type – Global Immunoglobulin G Antibody Therapeutics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Immunoglobulin G Antibody Therapeutics Market Size, 2022 & 2029
5.1.2 Autoimmune
5.1.3 Tumor
5.1.4 Others
5.2 By Application – Global Immunoglobulin G Antibody Therapeutics Revenue & Forecasts
5.2.1 By Application – Global Immunoglobulin G Antibody Therapeutics Revenue, 2018-2023
5.2.2 By Application – Global Immunoglobulin G Antibody Therapeutics Revenue, 2024-2029
5.2.3 By Application – Global Immunoglobulin G Antibody Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Immunoglobulin G Antibody Therapeutics Market Size, 2022 & 2029
6.2 By Region – Global Immunoglobulin G Antibody Therapeutics Revenue & Forecasts
6.2.1 By Region – Global Immunoglobulin G Antibody Therapeutics Revenue, 2018-2023
6.2.2 By Region – Global Immunoglobulin G Antibody Therapeutics Revenue, 2024-2029
6.2.3 By Region – Global Immunoglobulin G Antibody Therapeutics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Immunoglobulin G Antibody Therapeutics Revenue, 2018-2029
6.3.2 US Immunoglobulin G Antibody Therapeutics Market Size, 2018-2029
6.3.3 Canada Immunoglobulin G Antibody Therapeutics Market Size, 2018-2029
6.3.4 Mexico Immunoglobulin G Antibody Therapeutics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Immunoglobulin G Antibody Therapeutics Revenue, 2018-2029
6.4.2 Germany Immunoglobulin G Antibody Therapeutics Market Size, 2018-2029
6.4.3 France Immunoglobulin G Antibody Therapeutics Market Size, 2018-2029
6.4.4 U.K. Immunoglobulin G Antibody Therapeutics Market Size, 2018-2029
6.4.5 Italy Immunoglobulin G Antibody Therapeutics Market Size, 2018-2029
6.4.6 Russia Immunoglobulin G Antibody Therapeutics Market Size, 2018-2029
6.4.7 Nordic Countries Immunoglobulin G Antibody Therapeutics Market Size, 2018-2029
6.4.8 Benelux Immunoglobulin G Antibody Therapeutics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Immunoglobulin G Antibody Therapeutics Revenue, 2018-2029
6.5.2 China Immunoglobulin G Antibody Therapeutics Market Size, 2018-2029
6.5.3 Japan Immunoglobulin G Antibody Therapeutics Market Size, 2018-2029
6.5.4 South Korea Immunoglobulin G Antibody Therapeutics Market Size, 2018-2029
6.5.5 Southeast Asia Immunoglobulin G Antibody Therapeutics Market Size, 2018-2029
6.5.6 India Immunoglobulin G Antibody Therapeutics Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Immunoglobulin G Antibody Therapeutics Revenue, 2018-2029
6.6.2 Brazil Immunoglobulin G Antibody Therapeutics Market Size, 2018-2029
6.6.3 Argentina Immunoglobulin G Antibody Therapeutics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Immunoglobulin G Antibody Therapeutics Revenue, 2018-2029
6.7.2 Turkey Immunoglobulin G Antibody Therapeutics Market Size, 2018-2029
6.7.3 Israel Immunoglobulin G Antibody Therapeutics Market Size, 2018-2029
6.7.4 Saudi Arabia Immunoglobulin G Antibody Therapeutics Market Size, 2018-2029
6.7.5 UAE Immunoglobulin G Antibody Therapeutics Market Size, 2018-2029
7 Immunoglobulin G Antibody Therapeutics Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Immunoglobulin G Antibody Therapeutics Major Product Offerings
7.1.4 Roche Immunoglobulin G Antibody Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Abbvie
7.2.1 Abbvie Company Summary
7.2.2 Abbvie Business Overview
7.2.3 Abbvie Immunoglobulin G Antibody Therapeutics Major Product Offerings
7.2.4 Abbvie Immunoglobulin G Antibody Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Abbvie Key News & Latest Developments
7.3 J & J
7.3.1 J & J Company Summary
7.3.2 J & J Business Overview
7.3.3 J & J Immunoglobulin G Antibody Therapeutics Major Product Offerings
7.3.4 J & J Immunoglobulin G Antibody Therapeutics Revenue in Global Market (2018-2023)
7.3.5 J & J Key News & Latest Developments
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Company Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Immunoglobulin G Antibody Therapeutics Major Product Offerings
7.4.4 Bristol-Myers Squibb Immunoglobulin G Antibody Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Bristol-Myers Squibb Key News & Latest Developments
7.5 Novartis
7.5.1 Novartis Company Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Immunoglobulin G Antibody Therapeutics Major Product Offerings
7.5.4 Novartis Immunoglobulin G Antibody Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Novartis Key News & Latest Developments
7.6 Merck
7.6.1 Merck Company Summary
7.6.2 Merck Business Overview
7.6.3 Merck Immunoglobulin G Antibody Therapeutics Major Product Offerings
7.6.4 Merck Immunoglobulin G Antibody Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Merck Key News & Latest Developments
7.7 Alexion Pharmaceuticals
7.7.1 Alexion Pharmaceuticals Company Summary
7.7.2 Alexion Pharmaceuticals Business Overview
7.7.3 Alexion Pharmaceuticals Immunoglobulin G Antibody Therapeutics Major Product Offerings
7.7.4 Alexion Pharmaceuticals Immunoglobulin G Antibody Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Alexion Pharmaceuticals Key News & Latest Developments
7.8 Takeda
7.8.1 Takeda Company Summary
7.8.2 Takeda Business Overview
7.8.3 Takeda Immunoglobulin G Antibody Therapeutics Major Product Offerings
7.8.4 Takeda Immunoglobulin G Antibody Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Takeda Key News & Latest Developments
7.9 Amgen
7.9.1 Amgen Company Summary
7.9.2 Amgen Business Overview
7.9.3 Amgen Immunoglobulin G Antibody Therapeutics Major Product Offerings
7.9.4 Amgen Immunoglobulin G Antibody Therapeutics Revenue in Global Market (2018-2023)
7.9.5 Amgen Key News & Latest Developments
7.10 Biogen
7.10.1 Biogen Company Summary
7.10.2 Biogen Business Overview
7.10.3 Biogen Immunoglobulin G Antibody Therapeutics Major Product Offerings
7.10.4 Biogen Immunoglobulin G Antibody Therapeutics Revenue in Global Market (2018-2023)
7.10.5 Biogen Key News & Latest Developments
7.11 UCB
7.11.1 UCB Company Summary
7.11.2 UCB Business Overview
7.11.3 UCB Immunoglobulin G Antibody Therapeutics Major Product Offerings
7.11.4 UCB Immunoglobulin G Antibody Therapeutics Revenue in Global Market (2018-2023)
7.11.5 UCB Key News & Latest Developments
7.12 Eli Lilly and Company
7.12.1 Eli Lilly and Company Company Summary
7.12.2 Eli Lilly and Company Business Overview
7.12.3 Eli Lilly and Company Immunoglobulin G Antibody Therapeutics Major Product Offerings
7.12.4 Eli Lilly and Company Immunoglobulin G Antibody Therapeutics Revenue in Global Market (2018-2023)
7.12.5 Eli Lilly and Company Key News & Latest Developments
7.13 AstraZeneca
7.13.1 AstraZeneca Company Summary
7.13.2 AstraZeneca Business Overview
7.13.3 AstraZeneca Immunoglobulin G Antibody Therapeutics Major Product Offerings
7.13.4 AstraZeneca Immunoglobulin G Antibody Therapeutics Revenue in Global Market (2018-2023)
7.13.5 AstraZeneca Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Immunoglobulin G Antibody Therapeutics Market Opportunities & Trends in Global Market
Table 2. Immunoglobulin G Antibody Therapeutics Market Drivers in Global Market
Table 3. Immunoglobulin G Antibody Therapeutics Market Restraints in Global Market
Table 4. Key Players of Immunoglobulin G Antibody Therapeutics in Global Market
Table 5. Top Immunoglobulin G Antibody Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Immunoglobulin G Antibody Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Immunoglobulin G Antibody Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Immunoglobulin G Antibody Therapeutics Product Type
Table 9. List of Global Tier 1 Immunoglobulin G Antibody Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immunoglobulin G Antibody Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Immunoglobulin G Antibody Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Immunoglobulin G Antibody Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Immunoglobulin G Antibody Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Immunoglobulin G Antibody Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Immunoglobulin G Antibody Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Immunoglobulin G Antibody Therapeutics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2024-2029
Table 30. Roche Company Summary
Table 31. Roche Immunoglobulin G Antibody Therapeutics Product Offerings
Table 32. Roche Immunoglobulin G Antibody Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Roche Key News & Latest Developments
Table 34. Abbvie Company Summary
Table 35. Abbvie Immunoglobulin G Antibody Therapeutics Product Offerings
Table 36. Abbvie Immunoglobulin G Antibody Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Abbvie Key News & Latest Developments
Table 38. J & J Company Summary
Table 39. J & J Immunoglobulin G Antibody Therapeutics Product Offerings
Table 40. J & J Immunoglobulin G Antibody Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. J & J Key News & Latest Developments
Table 42. Bristol-Myers Squibb Company Summary
Table 43. Bristol-Myers Squibb Immunoglobulin G Antibody Therapeutics Product Offerings
Table 44. Bristol-Myers Squibb Immunoglobulin G Antibody Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Bristol-Myers Squibb Key News & Latest Developments
Table 46. Novartis Company Summary
Table 47. Novartis Immunoglobulin G Antibody Therapeutics Product Offerings
Table 48. Novartis Immunoglobulin G Antibody Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Immunoglobulin G Antibody Therapeutics Product Offerings
Table 52. Merck Immunoglobulin G Antibody Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. Merck Key News & Latest Developments
Table 54. Alexion Pharmaceuticals Company Summary
Table 55. Alexion Pharmaceuticals Immunoglobulin G Antibody Therapeutics Product Offerings
Table 56. Alexion Pharmaceuticals Immunoglobulin G Antibody Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Alexion Pharmaceuticals Key News & Latest Developments
Table 58. Takeda Company Summary
Table 59. Takeda Immunoglobulin G Antibody Therapeutics Product Offerings
Table 60. Takeda Immunoglobulin G Antibody Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. Takeda Key News & Latest Developments
Table 62. Amgen Company Summary
Table 63. Amgen Immunoglobulin G Antibody Therapeutics Product Offerings
Table 64. Amgen Immunoglobulin G Antibody Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 65. Amgen Key News & Latest Developments
Table 66. Biogen Company Summary
Table 67. Biogen Immunoglobulin G Antibody Therapeutics Product Offerings
Table 68. Biogen Immunoglobulin G Antibody Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 69. Biogen Key News & Latest Developments
Table 70. UCB Company Summary
Table 71. UCB Immunoglobulin G Antibody Therapeutics Product Offerings
Table 72. UCB Immunoglobulin G Antibody Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 73. UCB Key News & Latest Developments
Table 74. Eli Lilly and Company Company Summary
Table 75. Eli Lilly and Company Immunoglobulin G Antibody Therapeutics Product Offerings
Table 76. Eli Lilly and Company Immunoglobulin G Antibody Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 77. Eli Lilly and Company Key News & Latest Developments
Table 78. AstraZeneca Company Summary
Table 79. AstraZeneca Immunoglobulin G Antibody Therapeutics Product Offerings
Table 80. AstraZeneca Immunoglobulin G Antibody Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 81. AstraZeneca Key News & Latest Developments
List of Figures
Figure 1. Immunoglobulin G Antibody Therapeutics Segment by Type in 2022
Figure 2. Immunoglobulin G Antibody Therapeutics Segment by Application in 2022
Figure 3. Global Immunoglobulin G Antibody Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Immunoglobulin G Antibody Therapeutics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Immunoglobulin G Antibody Therapeutics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Immunoglobulin G Antibody Therapeutics Revenue in 2022
Figure 8. By Type - Global Immunoglobulin G Antibody Therapeutics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Immunoglobulin G Antibody Therapeutics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Immunoglobulin G Antibody Therapeutics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Immunoglobulin G Antibody Therapeutics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Immunoglobulin G Antibody Therapeutics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Immunoglobulin G Antibody Therapeutics Revenue Market Share, 2018-2029
Figure 16. US Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Immunoglobulin G Antibody Therapeutics Revenue Market Share, 2018-2029
Figure 20. Germany Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 21. France Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Immunoglobulin G Antibody Therapeutics Revenue Market Share, 2018-2029
Figure 28. China Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 32. India Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Immunoglobulin G Antibody Therapeutics Revenue Market Share, 2018-2029
Figure 34. Brazil Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Immunoglobulin G Antibody Therapeutics Revenue Market Share, 2018-2029
Figure 37. Turkey Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Immunoglobulin G Antibody Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 41. Roche Immunoglobulin G Antibody Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Abbvie Immunoglobulin G Antibody Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. J & J Immunoglobulin G Antibody Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bristol-Myers Squibb Immunoglobulin G Antibody Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Novartis Immunoglobulin G Antibody Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Merck Immunoglobulin G Antibody Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Alexion Pharmaceuticals Immunoglobulin G Antibody Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Takeda Immunoglobulin G Antibody Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Amgen Immunoglobulin G Antibody Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Biogen Immunoglobulin G Antibody Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. UCB Immunoglobulin G Antibody Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Eli Lilly and Company Immunoglobulin G Antibody Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. AstraZeneca Immunoglobulin G Antibody Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 免疫グロブリンG抗体治療薬の世界市場見通し2023年-2029年(Immunoglobulin G Antibody Therapeutics Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

免疫グロブリンG抗体治療薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp